Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation
Graft-versus-host disease (GVHD) is the commonest complication after donor lymphocyte infusion (DLI). In 19 patients undergoing DLI for relapses of hematologic malignancies post hematopoietic stem cell transplantation (HSCT), 11 developed GVHD, of whom nine had isolated liver involvement, and two ha...
Gespeichert in:
| Veröffentlicht in: | Bone marrow transplantation (Basingstoke) 2004-07, Vol.34 (1), p.57-61 |
|---|---|
| Hauptverfasser: | , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 61 |
|---|---|
| container_issue | 1 |
| container_start_page | 57 |
| container_title | Bone marrow transplantation (Basingstoke) |
| container_volume | 34 |
| creator | MA, S. Y AN, W. Y LIE, A. K. W NG, I. O. L LEUNG, A. Y. H TSE, E. W LIANG, R. H LAU, G. K KWONG, Y. L |
| description | Graft-versus-host disease (GVHD) is the commonest complication after donor lymphocyte infusion (DLI). In 19 patients undergoing DLI for relapses of hematologic malignancies post hematopoietic stem cell transplantation (HSCT), 11 developed GVHD, of whom nine had isolated liver involvement, and two had liver and skin involvement. The clinical diagnosis of liver GVHD was hepatitic in six patients (55%) and classical in five patients (45%). Patients with GVHD post-DLI showed a different clinical pattern when compared to a cohort of 106 cases of GVHD post-HSCT, in having significantly more isolated liver involvement (9/11 vs 17/106, P |
| doi_str_mv | 10.1038/sj.bmt.1704522 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_66651955</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A182414237</galeid><sourcerecordid>A182414237</sourcerecordid><originalsourceid>FETCH-LOGICAL-c539t-7d4c799a4019a41c02666a4aa0bb60c31dd6e2bf4fc9ebcfc3bd6e27eb5880993</originalsourceid><addsrcrecordid>eNqFkt-L1DAQx4so3nn66ptSFO-ta9I26fbxOPwFC77oc0nTyW6WNKmZ9GD_G_9Up2zhTjmQQH7MfOY7mWSy7DVnG86q7Uc8bvoxbXjDalGWT7JLXjeyEJUUT7NLVsptUVWyvcheIB4Z43XNxPPsggsuJJflZfZ7Z-8g5vuoTCpohzMWh4ApHyyCQsjJTv4h-BBzdxqnQ9CnBLn1ZkYbfG7IHsGpCQHzYPIDjCoFF_ZW56Nydu-V15Z806KqHHnAAznP4BQsJDphgjHX4FyeovI4OeWTSpTgZfbMKIfwal2vsp-fP_24_Vrsvn_5dnuzK7So2lQ0Q62btlU14zRxTaVLqWqlWN9Lpis-DBLK3tRGt9Bro6t-MTTQi-2WtW11lV2fdacYfs2AqRstLhdSHsKMHckJ3grxX5A327Iuq5rAd_-AxzBHT0V0JZeyanlZEfT-DO2Vg45eNVD9elHsbjgJcZJqiNo8QtEYYLQ6eDCW7H8FXD8IOIBy6YDBzcuL4qPKOgbECKaboh1VPHWcdUuHdXjsqMO6tcMo4O1a1dyPMNzja0sR8GEFFGrlTFz-Hx9wLRdNu3BvzpxXaY5wD6yJ_gANfuYV</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>216639123</pqid></control><display><type>article</type><title>Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><creator>MA, S. Y ; AN, W. Y ; LIE, A. K. W ; NG, I. O. L ; LEUNG, A. Y. H ; TSE, E. W ; LIANG, R. H ; LAU, G. K ; KWONG, Y. L</creator><creatorcontrib>MA, S. Y ; AN, W. Y ; LIE, A. K. W ; NG, I. O. L ; LEUNG, A. Y. H ; TSE, E. W ; LIANG, R. H ; LAU, G. K ; KWONG, Y. L</creatorcontrib><description>Graft-versus-host disease (GVHD) is the commonest complication after donor lymphocyte infusion (DLI). In 19 patients undergoing DLI for relapses of hematologic malignancies post hematopoietic stem cell transplantation (HSCT), 11 developed GVHD, of whom nine had isolated liver involvement, and two had liver and skin involvement. The clinical diagnosis of liver GVHD was hepatitic in six patients (55%) and classical in five patients (45%). Patients with GVHD post-DLI showed a different clinical pattern when compared to a cohort of 106 cases of GVHD post-HSCT, in having significantly more isolated liver involvement (9/11 vs 17/106, P<0.001), and less skin (2/11 vs 80/106, P<0.001) and gut (0/11 vs 28/106, P<0.001) involvement. However, liver GVHD post-DLI and post-HSCT had comparable patient characteristics, underlying diseases, clinical subtypes (classical and hepatitic) and response to treatment.</description><identifier>ISSN: 0268-3369</identifier><identifier>EISSN: 1476-5365</identifier><identifier>DOI: 10.1038/sj.bmt.1704522</identifier><identifier>PMID: 15156162</identifier><identifier>CODEN: BMTRE9</identifier><language>eng</language><publisher>Basingstoke: Nature Publishing Group</publisher><subject>Adolescent ; Adult ; Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Biological and medical sciences ; Bone marrow ; Bone marrow, stem cells transplantation. Graft versus host reaction ; Care and treatment ; Diagnosis ; Female ; Graft versus host reaction ; Graft vs Host Disease - drug therapy ; Graft vs Host Disease - etiology ; Graft vs Host Disease - pathology ; Hematologic Neoplasms - complications ; Hematologic Neoplasms - therapy ; Hematopoietic Stem Cell Transplantation - adverse effects ; Hematopoietic Stem Cell Transplantation - methods ; Hematopoietic stem cells ; Humans ; Liver cancer ; Liver Diseases - drug therapy ; Liver Diseases - etiology ; Lymphocyte Transfusion - adverse effects ; Male ; Medical sciences ; Middle Aged ; Prevention ; Recurrence ; Retrospective Studies ; Risk factors ; Stem cell transplantation ; Transfusions. Complications. Transfusion reactions. Cell and gene therapy ; Transplantation ; Transplantation, Homologous ; Treatment Outcome</subject><ispartof>Bone marrow transplantation (Basingstoke), 2004-07, Vol.34 (1), p.57-61</ispartof><rights>2004 INIST-CNRS</rights><rights>COPYRIGHT 2004 Nature Publishing Group</rights><rights>Copyright Nature Publishing Group Jul 2004</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c539t-7d4c799a4019a41c02666a4aa0bb60c31dd6e2bf4fc9ebcfc3bd6e27eb5880993</citedby><cites>FETCH-LOGICAL-c539t-7d4c799a4019a41c02666a4aa0bb60c31dd6e2bf4fc9ebcfc3bd6e27eb5880993</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27915,27916</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=15915792$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15156162$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MA, S. Y</creatorcontrib><creatorcontrib>AN, W. Y</creatorcontrib><creatorcontrib>LIE, A. K. W</creatorcontrib><creatorcontrib>NG, I. O. L</creatorcontrib><creatorcontrib>LEUNG, A. Y. H</creatorcontrib><creatorcontrib>TSE, E. W</creatorcontrib><creatorcontrib>LIANG, R. H</creatorcontrib><creatorcontrib>LAU, G. K</creatorcontrib><creatorcontrib>KWONG, Y. L</creatorcontrib><title>Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation</title><title>Bone marrow transplantation (Basingstoke)</title><addtitle>Bone Marrow Transplant</addtitle><description>Graft-versus-host disease (GVHD) is the commonest complication after donor lymphocyte infusion (DLI). In 19 patients undergoing DLI for relapses of hematologic malignancies post hematopoietic stem cell transplantation (HSCT), 11 developed GVHD, of whom nine had isolated liver involvement, and two had liver and skin involvement. The clinical diagnosis of liver GVHD was hepatitic in six patients (55%) and classical in five patients (45%). Patients with GVHD post-DLI showed a different clinical pattern when compared to a cohort of 106 cases of GVHD post-HSCT, in having significantly more isolated liver involvement (9/11 vs 17/106, P<0.001), and less skin (2/11 vs 80/106, P<0.001) and gut (0/11 vs 28/106, P<0.001) involvement. However, liver GVHD post-DLI and post-HSCT had comparable patient characteristics, underlying diseases, clinical subtypes (classical and hepatitic) and response to treatment.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Biological and medical sciences</subject><subject>Bone marrow</subject><subject>Bone marrow, stem cells transplantation. Graft versus host reaction</subject><subject>Care and treatment</subject><subject>Diagnosis</subject><subject>Female</subject><subject>Graft versus host reaction</subject><subject>Graft vs Host Disease - drug therapy</subject><subject>Graft vs Host Disease - etiology</subject><subject>Graft vs Host Disease - pathology</subject><subject>Hematologic Neoplasms - complications</subject><subject>Hematologic Neoplasms - therapy</subject><subject>Hematopoietic Stem Cell Transplantation - adverse effects</subject><subject>Hematopoietic Stem Cell Transplantation - methods</subject><subject>Hematopoietic stem cells</subject><subject>Humans</subject><subject>Liver cancer</subject><subject>Liver Diseases - drug therapy</subject><subject>Liver Diseases - etiology</subject><subject>Lymphocyte Transfusion - adverse effects</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prevention</subject><subject>Recurrence</subject><subject>Retrospective Studies</subject><subject>Risk factors</subject><subject>Stem cell transplantation</subject><subject>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</subject><subject>Transplantation</subject><subject>Transplantation, Homologous</subject><subject>Treatment Outcome</subject><issn>0268-3369</issn><issn>1476-5365</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><recordid>eNqFkt-L1DAQx4so3nn66ptSFO-ta9I26fbxOPwFC77oc0nTyW6WNKmZ9GD_G_9Up2zhTjmQQH7MfOY7mWSy7DVnG86q7Uc8bvoxbXjDalGWT7JLXjeyEJUUT7NLVsptUVWyvcheIB4Z43XNxPPsggsuJJflZfZ7Z-8g5vuoTCpohzMWh4ApHyyCQsjJTv4h-BBzdxqnQ9CnBLn1ZkYbfG7IHsGpCQHzYPIDjCoFF_ZW56Nydu-V15Z806KqHHnAAznP4BQsJDphgjHX4FyeovI4OeWTSpTgZfbMKIfwal2vsp-fP_24_Vrsvn_5dnuzK7So2lQ0Q62btlU14zRxTaVLqWqlWN9Lpis-DBLK3tRGt9Bro6t-MTTQi-2WtW11lV2fdacYfs2AqRstLhdSHsKMHckJ3grxX5A327Iuq5rAd_-AxzBHT0V0JZeyanlZEfT-DO2Vg45eNVD9elHsbjgJcZJqiNo8QtEYYLQ6eDCW7H8FXD8IOIBy6YDBzcuL4qPKOgbECKaboh1VPHWcdUuHdXjsqMO6tcMo4O1a1dyPMNzja0sR8GEFFGrlTFz-Hx9wLRdNu3BvzpxXaY5wD6yJ_gANfuYV</recordid><startdate>20040701</startdate><enddate>20040701</enddate><creator>MA, S. Y</creator><creator>AN, W. Y</creator><creator>LIE, A. K. W</creator><creator>NG, I. O. L</creator><creator>LEUNG, A. Y. H</creator><creator>TSE, E. W</creator><creator>LIANG, R. H</creator><creator>LAU, G. K</creator><creator>KWONG, Y. L</creator><general>Nature Publishing Group</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7QP</scope><scope>7T5</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20040701</creationdate><title>Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation</title><author>MA, S. Y ; AN, W. Y ; LIE, A. K. W ; NG, I. O. L ; LEUNG, A. Y. H ; TSE, E. W ; LIANG, R. H ; LAU, G. K ; KWONG, Y. L</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c539t-7d4c799a4019a41c02666a4aa0bb60c31dd6e2bf4fc9ebcfc3bd6e27eb5880993</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Biological and medical sciences</topic><topic>Bone marrow</topic><topic>Bone marrow, stem cells transplantation. Graft versus host reaction</topic><topic>Care and treatment</topic><topic>Diagnosis</topic><topic>Female</topic><topic>Graft versus host reaction</topic><topic>Graft vs Host Disease - drug therapy</topic><topic>Graft vs Host Disease - etiology</topic><topic>Graft vs Host Disease - pathology</topic><topic>Hematologic Neoplasms - complications</topic><topic>Hematologic Neoplasms - therapy</topic><topic>Hematopoietic Stem Cell Transplantation - adverse effects</topic><topic>Hematopoietic Stem Cell Transplantation - methods</topic><topic>Hematopoietic stem cells</topic><topic>Humans</topic><topic>Liver cancer</topic><topic>Liver Diseases - drug therapy</topic><topic>Liver Diseases - etiology</topic><topic>Lymphocyte Transfusion - adverse effects</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prevention</topic><topic>Recurrence</topic><topic>Retrospective Studies</topic><topic>Risk factors</topic><topic>Stem cell transplantation</topic><topic>Transfusions. Complications. Transfusion reactions. Cell and gene therapy</topic><topic>Transplantation</topic><topic>Transplantation, Homologous</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MA, S. Y</creatorcontrib><creatorcontrib>AN, W. Y</creatorcontrib><creatorcontrib>LIE, A. K. W</creatorcontrib><creatorcontrib>NG, I. O. L</creatorcontrib><creatorcontrib>LEUNG, A. Y. H</creatorcontrib><creatorcontrib>TSE, E. W</creatorcontrib><creatorcontrib>LIANG, R. H</creatorcontrib><creatorcontrib>LAU, G. K</creatorcontrib><creatorcontrib>KWONG, Y. L</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Immunology Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Bone marrow transplantation (Basingstoke)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MA, S. Y</au><au>AN, W. Y</au><au>LIE, A. K. W</au><au>NG, I. O. L</au><au>LEUNG, A. Y. H</au><au>TSE, E. W</au><au>LIANG, R. H</au><au>LAU, G. K</au><au>KWONG, Y. L</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation</atitle><jtitle>Bone marrow transplantation (Basingstoke)</jtitle><addtitle>Bone Marrow Transplant</addtitle><date>2004-07-01</date><risdate>2004</risdate><volume>34</volume><issue>1</issue><spage>57</spage><epage>61</epage><pages>57-61</pages><issn>0268-3369</issn><eissn>1476-5365</eissn><coden>BMTRE9</coden><abstract>Graft-versus-host disease (GVHD) is the commonest complication after donor lymphocyte infusion (DLI). In 19 patients undergoing DLI for relapses of hematologic malignancies post hematopoietic stem cell transplantation (HSCT), 11 developed GVHD, of whom nine had isolated liver involvement, and two had liver and skin involvement. The clinical diagnosis of liver GVHD was hepatitic in six patients (55%) and classical in five patients (45%). Patients with GVHD post-DLI showed a different clinical pattern when compared to a cohort of 106 cases of GVHD post-HSCT, in having significantly more isolated liver involvement (9/11 vs 17/106, P<0.001), and less skin (2/11 vs 80/106, P<0.001) and gut (0/11 vs 28/106, P<0.001) involvement. However, liver GVHD post-DLI and post-HSCT had comparable patient characteristics, underlying diseases, clinical subtypes (classical and hepatitic) and response to treatment.</abstract><cop>Basingstoke</cop><pub>Nature Publishing Group</pub><pmid>15156162</pmid><doi>10.1038/sj.bmt.1704522</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0268-3369 |
| ispartof | Bone marrow transplantation (Basingstoke), 2004-07, Vol.34 (1), p.57-61 |
| issn | 0268-3369 1476-5365 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_66651955 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Springer Nature - Complete Springer Journals; Nature Journals Online |
| subjects | Adolescent Adult Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Biological and medical sciences Bone marrow Bone marrow, stem cells transplantation. Graft versus host reaction Care and treatment Diagnosis Female Graft versus host reaction Graft vs Host Disease - drug therapy Graft vs Host Disease - etiology Graft vs Host Disease - pathology Hematologic Neoplasms - complications Hematologic Neoplasms - therapy Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods Hematopoietic stem cells Humans Liver cancer Liver Diseases - drug therapy Liver Diseases - etiology Lymphocyte Transfusion - adverse effects Male Medical sciences Middle Aged Prevention Recurrence Retrospective Studies Risk factors Stem cell transplantation Transfusions. Complications. Transfusion reactions. Cell and gene therapy Transplantation Transplantation, Homologous Treatment Outcome |
| title | Liver graft-versus-host disease after donor lymphocyte infusion for relapses of hematologic malignancies post allogeneic hematopoietic stem cell transplantation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T06%3A19%3A15IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liver%20graft-versus-host%20disease%20after%20donor%20lymphocyte%20infusion%20for%20relapses%20of%20hematologic%20malignancies%20post%20allogeneic%20hematopoietic%20stem%20cell%20transplantation&rft.jtitle=Bone%20marrow%20transplantation%20(Basingstoke)&rft.au=MA,%20S.%20Y&rft.date=2004-07-01&rft.volume=34&rft.issue=1&rft.spage=57&rft.epage=61&rft.pages=57-61&rft.issn=0268-3369&rft.eissn=1476-5365&rft.coden=BMTRE9&rft_id=info:doi/10.1038/sj.bmt.1704522&rft_dat=%3Cgale_proqu%3EA182414237%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=216639123&rft_id=info:pmid/15156162&rft_galeid=A182414237&rfr_iscdi=true |